MedPath

Multi-institutional study on cytoreuctive nephrectomy for unresctable or metastatic renal cell carcinoma

Not Applicable
Conditions
metastatic renal cell carcinoma
Registration Number
JPRN-jRCT1040220068
Lead Sponsor
Kumada Naotaka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
500
Inclusion Criteria

(i) Patients over 20 years old with metastatic renal cancer
(ii) Inpatients and outpatients

Exclusion Criteria

(1) Patients who are deemed ineligible for participation in this study by the principal investigator or subinvestigator of the medical institution where this study is conducted
(ii) Patients who have requested refusal of the research use of their information by opting out.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
overall survival
Secondary Outcome Measures
NameTimeMethod
Best overall response, progression-free survival, response rate, duration of response, safety, clinical usefulness rate<br>Patient Factors Affecting Response to Primary Resection and Adverse Events
© Copyright 2025. All Rights Reserved by MedPath